Novo Nordisk Pharma (Private) Limited, a global leader in diabetes care and Arogga Limited, Bangladesh’s leading online pharmacy platform, have signed a Memorandum of Understanding (MoU) to collaborate on improving patient convenience and access to authentic Novo Nordisk products through digital channels.
Under this collaboration, Arogga will provide online ordering and home delivery of Novo Nordisk products within Dhaka, ensuring cold-chain compliance and providing QR coded instructional materials for demonstrating correct product usage.
This initiative set a new benchmark for patient-centric innovation in Bangladesh, combining technology and accessibility while maintaining the highest compliance standards.
Among those present were Dr Mahbubur Rahman, director, Clinical, Medical & Regulatory of Novo Nordisk Pharma Pvt. Limited, Dr Mohammad Riad Mamun Prodhani, managing director of Novo Nordisk Pharma Pvt. Limited, Yawar Mehboob, co-founder & CSO of Arogga Limited, and Rosina Mazumder, co-founder & CEO of Arogga Limited.